Ionis Pharmaceuticals (IONS) EBT (2016 - 2025)
Historic EBT for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to -$128.4 million.
- Ionis Pharmaceuticals' EBT rose 1090.07% to -$128.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$259.4 million, marking a year-over-year increase of 2725.42%. This contributed to the annual value of -$460.7 million for FY2024, which is 3764.64% down from last year.
- As of Q3 2025, Ionis Pharmaceuticals' EBT stood at -$128.4 million, which was up 1090.07% from $123.5 million recorded in Q2 2025.
- In the past 5 years, Ionis Pharmaceuticals' EBT ranged from a high of $224.1 million in Q4 2021 and a low of -$146.8 million during Q1 2025
- Its 5-year average for EBT is -$65.0 million, with a median of -$83.8 million in 2021.
- In the last 5 years, Ionis Pharmaceuticals' EBT soared by 139964.62% in 2021 and then crashed by 296876.6% in 2024.
- Ionis Pharmaceuticals' EBT (Quarter) stood at $224.1 million in 2021, then plummeted by 120.01% to -$44.8 million in 2022, then skyrocketed by 92.17% to -$3.5 million in 2023, then crashed by 2968.77% to -$107.7 million in 2024, then decreased by 19.23% to -$128.4 million in 2025.
- Its EBT was -$128.4 million in Q3 2025, compared to $123.5 million in Q2 2025 and -$146.8 million in Q1 2025.